Nantahala Capital Management, LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$3.5T
Holdings
116
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (116 positions)
| Stock | Value |
|---|---|
IWMISHARES TR | $458.7B |
WWAYFAIR INC | $411.7B |
TLTISHARES TR | $173.2B |
ESTAESTABLISHMENT LABS HLDGS INC | $168.3B |
LNWOSCIENTIFIC GAMES CORP | $139.2B |
QUREUNIQURE NV | $119.2B |
IWOISHARES TR | $93.5B |
MLKNMILLER HERMAN INC | $88.0B |
CDXSCODEXIS INC | $87.5B |
—QAD INC | $80.6B |
—VONAGE HLDGS CORP | $79.5B |
CVNACARVANA CO | $61.5B |
IMAIMAX CORP | $60.0B |
THCTENET HEALTHCARE CORP | $58.7B |
CASHMETA FINL GROUP INC | $54.4B |
XBISPDR SER TR | $54.2B |
TNLTRAVEL PLUS LEISURE CO | $49.3B |
LXFRLUXFER HOLDINGS PLC | $46.6B |
SNDXSYNDAX PHARMACEUTICALS INC | $44.5B |
—SHIFT TECHNOLOGIES INC | $42.9B |
DXPEDXP ENTERPRISES INC | $42.6B |
TDOCTELADOC HEALTH INC | $39.9B |
SPRYSILVERBACK THERAPEUTICS INC | $39.1B |
TAUSDTRAVELCENTERS OF AMERICA INC | $37.7B |
GDENGOLDEN ENTMT INC | $32.5B |
CUECUE BIOPHARMA INC | $31.2B |
IMTXIMMATICS N.V | $29.5B |
ALTGALTA EQUIPMENT GROUP INC | $27.3B |
—FORTRESS BIOTECH INC | $26.9B |
IMXIINTERNATIONAL MNY EXPRESS IN | $25.6B |
RMRRMR GROUP INC | $25.5B |
KROSKEROS THERAPEUTICS INC | $25.4B |
—APTOSE BIOSCIENCES INC | $25.0B |
—METROMILE INC | $25.0B |
PTONPELOTON INTERACTIVE INC | $24.8B |
RDVTRED VIOLET INC | $23.5B |
DRIOEURDARIOHEALTH CORP | $22.7B |
—CERECOR INC | $20.7B |
BKEBUCKLE INC | $19.9B |
AKBAAKEBIA THERAPEUTICS INC | $19.6B |
—AKUMIN INC | $19.6B |
PWPPERELLA WEINBERG PARTNERS | $19.4B |
—BBQ HLDGS INC | $19.0B |
—APOLLO ENDOSURGERY INC | $18.8B |
PAYOPAYONEER GLOBAL INC | $18.8B |
IPOAGBPVIRGIN GALACTIC HOLDINGS INC | $18.4B |
—CURIS INC | $16.8B |
PAYAUSDPAYA HOLDINGS INC | $16.5B |
RDIREADING INTL INC | $16.1B |
HLFHERBALIFE NUTRITION LTD | $14.7B |
—FALCON MINERALS CORP | $13.3B |
—FINTECH ACQUISITION CORP V | $13.1B |
DHXDHI GROUP INC | $12.8B |
EXASEXACT SCIENCES CORP | $12.4B |
VMDVIEMED HEALTHCARE INC | $12.2B |
NAUTNAUTILUS BIOTECHNOLOGY INC | $12.0B |
WVEWAVE LIFE SCIENCES LTD | $11.9B |
AUTLAUTOLUS THERAPEUTICS PLC | $11.9B |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $11.7B |
LINCLINCOLN EDL SVCS CORP | $11.3B |
—SOLENO THERAPEUTICS INC | $11.1B |
GYRECATALYST BIOSCIENCES INC | $11.0B |
PAR 2.875 04/15/26PAR TECHNOLOGY CORP | $10.9B |
HOMEAT HOME GROUP INC | $10.5B |
—FTAC ATHENA ACQUISITION CORP | $10.2B |
—FINTECH ACQUISITION CORP VI | $10.1B |
—FTAC PARNASSUS ACQUISITN COR | $10.1B |
—INSU ACQUISITION CORP III | $10.1B |
—FTAC HERA ACQUISITION CORP | $10.0B |
—SOARING EAGLE ACQUISITION CO | $9.8B |
SRLSCULLY ROYALTY LTD | $9.5B |
PRTY1EURPARTY CITY HOLDCO INC | $9.3B |
TSHATAYSHA GENE THERAPIES INC | $9.2B |
ZVOIZOVIO INC | $8.1B |
CUCAAVIS BUDGET GROUP | $8.0B |
HCAHCA HEALTHCARE INC | $7.4B |
ACADACADIA PHARMACEUTICALS INC | $7.3B |
RILYB. RILEY FINANCIAL INC | $7.2B |
SSKNSTRATA SKIN SCIENCES INC | $7.2B |
—ZOGENIX INC | $6.7B |
—HARPOON THERAPEUTICS INC | $6.1B |
—DOVER MOTORSPORTS INC | $5.8B |
XGNEXAGEN INC | $5.5B |
RGSUSDREGIS CORP MINN | $5.1B |
—IKENA ONCOLOGY INC | $4.9B |
—IMAC HLDGS INC | $4.9B |
HOOKGBPHOOKIPA PHARMA INC | $4.7B |
—ELOXX PHARMACEUTICALS INC | $4.5B |
—ARYA SCIENCES ACQU CORP IV | $4.3B |
—LAVA THERAPEUTICS NV | $4.1B |
—ROTH CH ACQUISITION III CO | $4.1B |
—B RILEY PRINCIPAL 150 MERGER | $3.8B |
MACKEURMERRIMACK PHARMACEUTICALS IN | $3.7B |
TFFPEURTFF PHARMACEUTICALS INC | $3.5B |
NPCENEUROPACE INC | $3.5B |
—HEALTHCOR CATALIO ACQU CORP | $3.5B |
TORCEURADICET BIO INC | $3.2B |
TBHCKIRKLANDS INC | $3.0B |
GLMDGALMED PHARMACEUTICALS LTD | $2.9B |
—ACER THERAPEUTICS INC | $2.7B |
Page 1 of 2Next